肠易激综合征中医证候临床流行病学调查研究
|
摘要
目的：
依据文献分析制定肠易激综合征临床信息采集表,通过对广州中医药大学第一附属医院2011年8月-2012年4月就诊的IBS患者临床信息调查研究,分析目前IBS临床流行病学特点,包括一般情况、诱发及加重因素等；根据中医四诊资料,分析TBS的中医证候特点,及其与“肝主疏泄”的相关性,进一步为IBS的预防、控制和治疗评价提供依据。
方法：
查询各数据库收录近年来有关IBS的现代研究文献,提取相关的症状、证候要素、证候,总结IBS可能的病因病机与证治规律,据此制定IBS临床信息采集表。应用IBS临床信息采集表对广州中医药大学第一附属医院2011年8月-2012年4月就诊的IBS患者进行临床信息采集,利用频数分析方法对流行病学资料进行分析,探讨肠易激综合征临床流行病学特点；利用频数分析、因子分析、聚类分析,结合证素辨证体系探索肠易激综合征的中医证候特点,并与调查时所使用的《中医消化病学诊疗指南》的辨证分型标准的证候进行比较,分析其适用性和指导意义；并进一步根据中医证候特点探讨肠易激综合征与“肝主疏泄”的相关性。
结果：
本研究共收集104例肠易激综合征患者,其中腹泻型占90.4%；女性占64.4%；男：女为1：1.81；青年者占69.2%；文化程度为大学和(或)以上者占52.9%；经济收入一般者占79.8%；在职者及学生合占比例为76.9%；平素饮食口味有偏好者占51.0%；IBS发生的诱因或加重的原因与季节相关的占29.8%,夏季比例最大(16.3%)。77.9%IBS患者病情反复或加重有其他原因诱发,劳累占21.2%,饮酒有10.6%,受凉占30.8%,饮食不慎占59.6%,情绪因素中紧张比例最大,占39.4%。
IBS患者表现为腹胀者占57.5%,饭后腹胀或排便后腹胀缓解者占53.8%；IBS患者表现为腹痛者占71.2%,排便后腹痛缓解者占47.1%；大便次数增多者占88.5%,粪质偏烂者占91.3%；痛泻者占76.9%；有便秘(大便次数减少)者占16.3%。约2／3IBS患者具有情绪精神症状,烦躁者占56.7%；急躁易怒者占49.0%；精神抑郁者占57.7%；焦虑者占48.1%；忧郁者占43.3%；紧张者占53.8%；情绪低落者占37.5%。中医诊断,便秘者占5.8%；腹痛者占43.3%；泄泻者占51.0%；证候分型中肝郁脾虚比例最大,占85.6%：肝郁气滞者占2.9%；脾肾阳虚者占3.8%：脾胃湿热者占7.7%。通过因子分析、聚类分析、证素辨证体系及专家临床经验,初步认为在聚为5类,分为4型(脾胃虚弱、肝胂不和、肝郁脾虚、脾胃湿热)时,症状指标分散性良好,证型分布清晰,因此考虑本研究分为4种证型时最为符合统计学要求及临床实际情况。
结论：
IBS忠者各亚型中以腹泻型最多；女性比男性更易患病；发病人群分布以青年居多；文化程度较高、经济收入一般的人群更易患IBS:IBS患者饮食倾向于进食海鲜、辣椒,夏季常可诱发或加重IBS症状；IBS患者普遍有较差的精神状态,精神因素为IBS发病的重要原因之一。IBS常以腹痛、腹胀、腹泻、便秘为首发症状：IBS忠者同时容易出现功能性消化不良症状、结肠外症状。IBS中医病机常责之为肝郁脾虚,不同病变阶段的临床表现均不相同,但基本病机总离不开肝郁脾虚,肝郁脾虚贯穿于疾病发展的始终。分析得出的肠易激综合征的证候特点基本与经验辨证及临床相符,证明数理统计及数据挖掘方法是可以用来科学、客观的支持临床诊断的。《中医消化病诊疗指南》所提出的对肠易激综合征辨证分型标准能基本代表广州地区肠易激综合征的证候特点,对IBS的治疗有较强的指导意义。
Object ive
Making a clinical information collection form based on literature research, through the clinical information research on the treatment of IBS patients by the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from August2011to April2012. Analyze the clinical epidemiological characteristics and TCM syndromes of IBS at present, and its correlation with Liver controlling dispersion, to provide the basis for the prevention, control and treatment evaluation of IBS.
Methods
Check the indexed modern research literature in recent years with IBS, extraction-related symptoms, the syndrome elements, syndrome, summed up the cause of IBS may pathogenesis and treatment of law, which established the IBS clinical information collection form. Use clinical information collection form to collect clinical information on the application of IBS patients who seek treatment in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from2012August to2011April, frequency analysis methods to analyze the epidemiological data, to investigate the clinical epidemiological features of irritable bowel syndrome, frequency analysis, factor analysis, cluster analysis, combined with syndrome differentiation system exploration of irritable bowel syndrome TCM syndromes, and compare with syndrome in "Chinese gastroenterol ogy diagnosis and treatment guidelines" when used the time of the survey syndrome, analyze its applicability and guiding significance, investigate IBS with "Liver controlling dispersion" according to TCM syndromes
Results
This study collected a total of104cases of irritable bowel syndrome, which accounted for90.4%of diarrhea-predominant, women accounted for64.4%, Male:female was1:1.81, youth accounted for69.2%, educational level accounted for52.9%of universities and (or) more, general economic and income accounted for79.8%, the incumbent and the students together accounted for76.9%, usually tastes preferences accounted for51.0%, IBS occur incentives or increase the causes and season accounted for29.8%, summer proportion (16.3%) is the largest,77.9%of IBS patients with recurrent disease or aggravate other causes induced, fatigue accounted for21.2%, alcohol10.6%,30.8%in cold diet inadvertently accounted for59.6%, the largest proportion of tension in the emotional factors, accounting for39.4%.
Performance of patients with IBS, abdominal distention (57.5%), bloating after meals, or bloating alleviate after defecation accounted for53.8%, manifested as abdominal pain (71.2%), after a bowel movement, abdominal pain accounted for47.1%, stool frequency increased by88.5%, partial rotten fecal matter accounted for91.3%, pain and diarrhea accounted for76.9%, constipation (stool frequency decrease) accounted for16.3%, about2/3of IBS patients with mood psychiatric symptoms, irritability, who accounted for56.7%, the irritability accounted for49.0%, depression accounted for57.7%, anxiety accounted for48.1%, depression accounted for43.3%, tension accounted for53.8%, depression accounted for37.5%, TCM diagnosis, constipation, accounting for5.8%, abdominal pain (43.3%), diarrhea accounted for51.0%, in syndrome type, the largest proportion of stagnation and spleen deficiency, accounting for85.6%, liver Qi stagnation, accounted for2.9%, spleen deficiency accounted for3.8%, spleen accounted for7.7%. Through factor analysis, cluster analysis, the syndrome differentiation system and expert clinical experience, the preliminary view that in clustered into five categories, divided into4types (spleen and stomach, liver and spleen, stagnation and spleen deficiency, spleen), the symptom index dispersion good, syndrome distribution is clear, so consider this study is divided into four kinds of card type is most consistent with the statistical requirements and the clinical practice.
Conclusion
Subtypes of IBS patients with diarrhea-predominant up to, women more susceptible than men, incidence population distribution the majority of youth, a higher educational level, general economic income of the population more prone to IBS, patients with IBS diet tend to eat seafood, peppers, summer important one of the reasons often can induce or aggravate symptoms of IBS, patients with IBS generally poor state of mind, mental factors for IBS incidence. IBS often with abdominal pain, bloating, diarrhea, constipation, as the first symptom, IBS patients are also prone to functional dyspepsia symptoms and symptoms of colon outside. Traditional Chinese medicine pathogenesis of IBS often responsible for the stagnation and spleen deficiency, different pathological stages of clinical manifestations vary, but the basic pathogenesis is always the stagnation and spleen deficiency, stagnation and spleen deficiency throughout the development of the disease is always. Analysis derived from irritable bowel syndrome syndrome characteristics are basically consistent with the dialectic of experience and clinical, mathematical statistics and data mining methods can be used to scientifically and objectively support clinical diagnosis. The Chinese gastroenterology diagnosis and treatment guidelines irritable bowel syndrome syndrome type standard basic on behalf of the Guangzhou area of irritable bowel syndrome syndrome characteristics, there is a strong guiding significance for the treatment of IBS.
依据文献分析制定肠易激综合征临床信息采集表,通过对广州中医药大学第一附属医院2011年8月-2012年4月就诊的IBS患者临床信息调查研究,分析目前IBS临床流行病学特点,包括一般情况、诱发及加重因素等；根据中医四诊资料,分析TBS的中医证候特点,及其与“肝主疏泄”的相关性,进一步为IBS的预防、控制和治疗评价提供依据。
方法：
查询各数据库收录近年来有关IBS的现代研究文献,提取相关的症状、证候要素、证候,总结IBS可能的病因病机与证治规律,据此制定IBS临床信息采集表。应用IBS临床信息采集表对广州中医药大学第一附属医院2011年8月-2012年4月就诊的IBS患者进行临床信息采集,利用频数分析方法对流行病学资料进行分析,探讨肠易激综合征临床流行病学特点；利用频数分析、因子分析、聚类分析,结合证素辨证体系探索肠易激综合征的中医证候特点,并与调查时所使用的《中医消化病学诊疗指南》的辨证分型标准的证候进行比较,分析其适用性和指导意义；并进一步根据中医证候特点探讨肠易激综合征与“肝主疏泄”的相关性。
结果：
本研究共收集104例肠易激综合征患者,其中腹泻型占90.4%；女性占64.4%；男：女为1：1.81；青年者占69.2%；文化程度为大学和(或)以上者占52.9%；经济收入一般者占79.8%；在职者及学生合占比例为76.9%；平素饮食口味有偏好者占51.0%；IBS发生的诱因或加重的原因与季节相关的占29.8%,夏季比例最大(16.3%)。77.9%IBS患者病情反复或加重有其他原因诱发,劳累占21.2%,饮酒有10.6%,受凉占30.8%,饮食不慎占59.6%,情绪因素中紧张比例最大,占39.4%。
IBS患者表现为腹胀者占57.5%,饭后腹胀或排便后腹胀缓解者占53.8%；IBS患者表现为腹痛者占71.2%,排便后腹痛缓解者占47.1%；大便次数增多者占88.5%,粪质偏烂者占91.3%；痛泻者占76.9%；有便秘(大便次数减少)者占16.3%。约2／3IBS患者具有情绪精神症状,烦躁者占56.7%；急躁易怒者占49.0%；精神抑郁者占57.7%；焦虑者占48.1%；忧郁者占43.3%；紧张者占53.8%；情绪低落者占37.5%。中医诊断,便秘者占5.8%；腹痛者占43.3%；泄泻者占51.0%；证候分型中肝郁脾虚比例最大,占85.6%：肝郁气滞者占2.9%；脾肾阳虚者占3.8%：脾胃湿热者占7.7%。通过因子分析、聚类分析、证素辨证体系及专家临床经验,初步认为在聚为5类,分为4型(脾胃虚弱、肝胂不和、肝郁脾虚、脾胃湿热)时,症状指标分散性良好,证型分布清晰,因此考虑本研究分为4种证型时最为符合统计学要求及临床实际情况。
结论：
IBS忠者各亚型中以腹泻型最多；女性比男性更易患病；发病人群分布以青年居多；文化程度较高、经济收入一般的人群更易患IBS:IBS患者饮食倾向于进食海鲜、辣椒,夏季常可诱发或加重IBS症状；IBS患者普遍有较差的精神状态,精神因素为IBS发病的重要原因之一。IBS常以腹痛、腹胀、腹泻、便秘为首发症状：IBS忠者同时容易出现功能性消化不良症状、结肠外症状。IBS中医病机常责之为肝郁脾虚,不同病变阶段的临床表现均不相同,但基本病机总离不开肝郁脾虚,肝郁脾虚贯穿于疾病发展的始终。分析得出的肠易激综合征的证候特点基本与经验辨证及临床相符,证明数理统计及数据挖掘方法是可以用来科学、客观的支持临床诊断的。《中医消化病诊疗指南》所提出的对肠易激综合征辨证分型标准能基本代表广州地区肠易激综合征的证候特点,对IBS的治疗有较强的指导意义。
Object ive
Making a clinical information collection form based on literature research, through the clinical information research on the treatment of IBS patients by the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from August2011to April2012. Analyze the clinical epidemiological characteristics and TCM syndromes of IBS at present, and its correlation with Liver controlling dispersion, to provide the basis for the prevention, control and treatment evaluation of IBS.
Methods
Check the indexed modern research literature in recent years with IBS, extraction-related symptoms, the syndrome elements, syndrome, summed up the cause of IBS may pathogenesis and treatment of law, which established the IBS clinical information collection form. Use clinical information collection form to collect clinical information on the application of IBS patients who seek treatment in the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from2012August to2011April, frequency analysis methods to analyze the epidemiological data, to investigate the clinical epidemiological features of irritable bowel syndrome, frequency analysis, factor analysis, cluster analysis, combined with syndrome differentiation system exploration of irritable bowel syndrome TCM syndromes, and compare with syndrome in "Chinese gastroenterol ogy diagnosis and treatment guidelines" when used the time of the survey syndrome, analyze its applicability and guiding significance, investigate IBS with "Liver controlling dispersion" according to TCM syndromes
Results
This study collected a total of104cases of irritable bowel syndrome, which accounted for90.4%of diarrhea-predominant, women accounted for64.4%, Male:female was1:1.81, youth accounted for69.2%, educational level accounted for52.9%of universities and (or) more, general economic and income accounted for79.8%, the incumbent and the students together accounted for76.9%, usually tastes preferences accounted for51.0%, IBS occur incentives or increase the causes and season accounted for29.8%, summer proportion (16.3%) is the largest,77.9%of IBS patients with recurrent disease or aggravate other causes induced, fatigue accounted for21.2%, alcohol10.6%,30.8%in cold diet inadvertently accounted for59.6%, the largest proportion of tension in the emotional factors, accounting for39.4%.
Performance of patients with IBS, abdominal distention (57.5%), bloating after meals, or bloating alleviate after defecation accounted for53.8%, manifested as abdominal pain (71.2%), after a bowel movement, abdominal pain accounted for47.1%, stool frequency increased by88.5%, partial rotten fecal matter accounted for91.3%, pain and diarrhea accounted for76.9%, constipation (stool frequency decrease) accounted for16.3%, about2/3of IBS patients with mood psychiatric symptoms, irritability, who accounted for56.7%, the irritability accounted for49.0%, depression accounted for57.7%, anxiety accounted for48.1%, depression accounted for43.3%, tension accounted for53.8%, depression accounted for37.5%, TCM diagnosis, constipation, accounting for5.8%, abdominal pain (43.3%), diarrhea accounted for51.0%, in syndrome type, the largest proportion of stagnation and spleen deficiency, accounting for85.6%, liver Qi stagnation, accounted for2.9%, spleen deficiency accounted for3.8%, spleen accounted for7.7%. Through factor analysis, cluster analysis, the syndrome differentiation system and expert clinical experience, the preliminary view that in clustered into five categories, divided into4types (spleen and stomach, liver and spleen, stagnation and spleen deficiency, spleen), the symptom index dispersion good, syndrome distribution is clear, so consider this study is divided into four kinds of card type is most consistent with the statistical requirements and the clinical practice.
Conclusion
Subtypes of IBS patients with diarrhea-predominant up to, women more susceptible than men, incidence population distribution the majority of youth, a higher educational level, general economic income of the population more prone to IBS, patients with IBS diet tend to eat seafood, peppers, summer important one of the reasons often can induce or aggravate symptoms of IBS, patients with IBS generally poor state of mind, mental factors for IBS incidence. IBS often with abdominal pain, bloating, diarrhea, constipation, as the first symptom, IBS patients are also prone to functional dyspepsia symptoms and symptoms of colon outside. Traditional Chinese medicine pathogenesis of IBS often responsible for the stagnation and spleen deficiency, different pathological stages of clinical manifestations vary, but the basic pathogenesis is always the stagnation and spleen deficiency, stagnation and spleen deficiency throughout the development of the disease is always. Analysis derived from irritable bowel syndrome syndrome characteristics are basically consistent with the dialectic of experience and clinical, mathematical statistics and data mining methods can be used to scientifically and objectively support clinical diagnosis. The Chinese gastroenterology diagnosis and treatment guidelines irritable bowel syndrome syndrome type standard basic on behalf of the Guangzhou area of irritable bowel syndrome syndrome characteristics, there is a strong guiding significance for the treatment of IBS.
引文
[1]Lule GN, Amayo EO. Irritable bowel syndrome in Kenyans[J]. East Afr Med J,2002,79(7): 360-363.
[2]Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America:a systematic review[J]. Am J Gastroenterol,2002,97(8):1910-1915.
[3]Ringel Y, Sperber AD, Dross man DA. Irritable bowel syndrome[J]. Annu Rev Med,2001, 52:319-338.
[4]Schmulson M, Ortiz O, Santiago-Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico city[J]. Dig Dis,2006,24(3-4):342-347.
[5]Chang FY, Lu CL Irritable bowel syndrome in the 21st century:perspectives from Asia or South-east Asia[J]. Gastroenterol Hepatol,2007,22(1):4-12.
[6]Vandvik P0, Lydersen S, Farup PG. Prevalence co morbidi ty and impact of irritable bowel syndrome in Norway[J]. Scand J Gastroenterol,2006,41(6):650-656.
[7]Celebi S, Acik Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society[J]. Gastroenterol Hepatol,2004,19:738-743.
[8]Kang JY. Systematic review:the influence of geography and ethnici ty in irri table bowel syndrome[J]. Aliment Pharmacol Ther,2005,21(3):663-676.
[9]Shinozaki M, Fukudo S, Hongo M, et al. High prevalence of irritable bowel syndrome in medical outpatients in Japan[J]. Gastroenterol,2008,42(9):1010-1016.
[10]Park KS, Ahn SH, Hwang JS, et al. A survey about irritable bowel syndrome in South Korea prevalence and observable organic abnormalities in IBS patients[J]. Dig Dis SCI, 2008,53(3):704-711.
[11]潘国宗,鲁素彩,柯美云,等.北京地区肠易激综合征的流行病学研究：一个整群、分层、随机的调查[J].中华流行病学杂志,2000,21(1)：26-28.
[12]熊理守,陈旻湖,陈惠新,等.广东省社区人群肠易激综合征的流行病学研究[J].中华医学杂志,2004,84：278-281.
[13]冯新伟,徐珊.香港特区老年人肠易激综合征流行病学调查分析[J].承德医学院学报,2009,11(1)：43-45.
[14]李定国,刘栋,许小幸,等.青少年儿童肠易激综介征的流行病学调查[J].中华消化杂志,2005,25(5)：266-269.
[15]周小玲,周立平，蔡文智.肠易激综合征的流行病学调查[J].中医药导报.2010,16(5)：98-100.
[16]罗莎,陈春华.南宁市肠易激综合征流行病学调查[J].中医误诊学杂志,2012,12(1)：130.
[17]Tamsel S, Demirpolat G, Killi R, et al. Primary hepatic actinormycosis a case of inflammatory pseudo tumor (case report)[J]. Tani Girisim Radyol,2004,10(2):154-157.
[18]Corapcioqlu F, Kargi A, Olgun N, et al. Inflammatory my of ibroblastic turn or of the ileocecal mesentery mimicking abdominal lymphoma in childhood report of two cases[J]. Surg Today,2005,35(8):687-691.
[19]陈毅斌,张宝庭,张锡迎,等.肠道感染后IBS与SERT基因多态性关系[J].现代医院,2010,10(3)：11-13.
[20]Whorwell PJ, McCalum M, Creed FH, et al. Non-colonic features of irritable bowel syndrome[J], Gut,1986,27:37-40.
[21]Yuri A, Gloria M, Joseph J, et al. Familial aggregation of irritable bowel syndrome: A family case control study[J]. Am J Gastroenterol,2010,105:838-841.
[22]Kanazawa M, Endo Y, Whitehead WE, et al. Patients and nonconsulters with irritable bowel problems have more impaired psychological distress[J]. Dig Dis Sci,1994,49: 1046-1953.
[23]高峰,王景杰,黄裕新,等.肠易激综合症16例胃肠运动功能临床探讨[J].陕西医学杂志,2007,8(8)：1903-1905.
[24]van der Voort IR, Osmanoglou E, SeyboldM, et al. Electrogastrography as a diagnostic tool fordelayed gastric emptying in functional and irritable bowel syndrome[J]. Neurogastroenterol Moti,2003,15(5):467-473.
[25]Portincasa P, Moschetta A, Baldassarre G, et al. Pan-enteric dysmo tility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome[J]. World J Gastroenterol,2003,9(10):2293-2299.
[26]陶琳,柯美云,王智凤.小肠细菌过度生长与功能性胃肠疾病的关系[J].中国中西医结合消化杂志,2005,13(2)：122-123.
[27]王景杰,高峰,黄欲新,等.IBS患者胃肠运动功能的临床研究[J].西安交通大学学报,23(4)：423-424.
[28]段建华,赵洪川.便秘型肠易激综合征患者结、直肠肛门动力学的临床研究[J].胃肠病学和肝病学杂志,2006,15(2)：191-193.
[29]Manabe N, Wong BS, Camilleri M, et al. Lower functional gastrointrstinal disorders: evidence of abnormal colonic transit in a 287 patient cohort [J]. Neurogastroenterol Motil, 2010,22(3):293-296.
[30]Staud R, Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia[J]. CNS Spectr,2008,13(3):12217.
[31]Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensivity in female patients with irritable bowel syndrome[J]. World J Gastroenterol,2007,13(27):3699-3704.
[32]姜敏,汤浩,刘峥艳,等.肠易激综合征内脏感知异常与临床症状的相关性[J].世界华人消化杂志,2005,13(4)：561-564.
[33]Holtmann G, oebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? [J]. Am J Gastroenterol,1997,92(2):954-959.
[34]Defilippi GC, Quera PR, Madrid SAM, et al. Rectal barosstat in irritable bowel syndrome[J]. Rev Med Chill,2006,134(12):1524-1529.
[35]Spaziani R, Bayati A, Redmond K, et al. Vagal dysfunction in irritable bowel syndrome assessed by trctal distension and baroreceptor Sensitity[J]. Neurogastroenterol Motil, 2008,20(4):336-342.
[36]张鸣鸣,姜敏.肠易激综合征发病机制研究进展[J].世界华人消化杂志,2009,17：2484-2490.
[37]Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome:a double-blind, randomized, placebo-controlled study[J]. Am J Gastroenterol,2003,98(2):412-419.
[38]Tornblom ll, Lindberg G, Nvberq B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome[J]. Gastroenterology, 2002,123(6):1972-1979.
[39]Wang LH, Fang XC, Pan GZ. Bacil lary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis[J]. Gut 2004,53:1096-1101.
[40]Jung IS, Kim HS, Park H, Lee SI. The clinical course of post infectious irritable bowel syndrome:a five-year follow-up study[J]. Clin Gastroenterol,2009,43:534-540.
[41]Mearin F, Perez-Oliveras M, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak:one-year follow-up cohort study[J]. Gastroenterology,2005,129:98-104.
[42]Spiller RC. Role of infection in irritable bowel syndrome [J]. Gastroenterol,2007, 42(17):41-47.
[43]O'M ahony L, Me Carthy J, Kelly P, et al. Lactobacillus and bifidobac-terium in irritable bowel syndrome:symptom responses and relation-ship to cytokine profiles[J]. Gastroenterology,2005,128(3):541-551.
[44]Wu HG, Jiang B, Zhou EH, et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome:preventing MC activation and decreasing SP VIP secretion[J]. Dig Dis Sci,2008,53:1644-1651.
[45]Shi XZ, Sarna SK. Gene therapy of Ca(v) 1.2 channel with VIP and VIP receptor agonists and antagonists:a novel approach to designing promotility and antimoti1ity agents[J]. Am J Physiol Gastrointest Liver Physiol,2008,295:G187 G196.
[46]Bnnks MR, FrthingMJ, Robbcrecht P, etal. Ant isccretory act ions of a novel vasoactive intestinal polypeptide antagonist in human and rat small intestine[J]. Br P J Pharmacol, 2005,144(7):994-1001.
[47]Wu CT, Eiserich JP, Gershwin ME, et al. M yeloperoxidase positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions[J]. Hepatology,2003,38(4):1018-1025.
[48]王晓,尹朝礼,胡道松,等.肠动力疾病结肠壁内NOS, AchE及SP阳性神经的分布[J].中华消化杂志,1997,17(4)：195.
[49]张忠兵,张学庸,邓敬兰,等.溃疡性结肠炎、肠易激综合征和慢性结肠炎病人黏膜中SP和V1P含量的初步探讨[J].中华消化杂志,1993,13(2)：93.
[50]林琳,赵志泉,殷咏梅,等.胃肠激素与肠易激综合征的相关性[J].江苏医药杂志,2001,27(3)：166.
[51]杨云生,张万岱,潘德寿,等.肠易激综合征血浆及乙状结肠黏膜中CCK及SP的含量[J].消化病学杂志,1997,5(7)：437.
[52]Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydrox-ytryptamine in diarrhoea predominant irritable bowel syndrome:a pilot study [J]. Gut,1998,42(1):42.
[53]Grider JR, Piland BE. The peristaltic reflex induced by short-chain Fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF[J]. Am J Physiol Gastrointest Liver Physiol,2007,292(1):G429-G437.
[54]Miwa J, Echizen H, Matsueda K, etal. Patients with constipation prediminant irritable bowel syndrome may have elevated sero-tonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits[J]. Diges-tion, 2001,63(3):188.
[55]Gorard DA, Dewsnap PA, Medbak SH, et al. Central 5-hydroxytryp-taminergic function in irritable bowel syndrome[J]. Scared J Gastroen-terol,1995,30(10):994.
[56]Spiller RC, Jenkins D, Thornley JP, et al. Increased rental mucosal enteroendocrine cells T lymphocytes end increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome[J]. Gut,2000,47(6):804.
[57]Bose M, Nickols C, Feakins R, etal.5-hydroxytrypatamine and enterochapmaffin cells in the irritable bowel syndrome[J]. Gastroenterology,2000,118:A563.
[58]Sjolund K, Ekman R, Lindgren S, etal. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome[J]. Scand-J-Gas-troenterol,1996,31(11):1110.
[59]谢勇,黄缘.王崇文,等.肠易激综合征乙状结肠粘膜内胃肠激素及一氧化氮的变化[J].中国内镜杂志,1997,3(6)：17.
[60]Gui X-Y. Mast sells:A possiblc link between psychological stress enteric infection food allergy and gut hypersensitivity in the irritable bowel syndrome[J]. J Gastroenterology and Hepatology,1998,13(10):980.
[6l]Talley NJ. Serotoninegic neuroenteric modulators[J]. Lancet,2001,358(9298):2061.
[62]杨云生,张振书,宋于刚,等.肠易激综合征发病机制的初步研究[J].中国病理生理志,1998,14(4)：395.
[63]王彝康,龙汉宁,孙依萍,等.肠易激综合征患者胃肠激素变化[J].胃肠病学,2001,6(2)1]6.
[64]Harvey RF, Read AE. Effects of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome[J]. Lan-cet,1973,1(7793):1-3.
[65]Kellow JE, Phillips SF, Mller LJ, et al. Dysmotility of the small intes-tine in irritable bowel syndrome[J]. Gut,1988,29(9):1236-1243.
[66]Thomson IR, Fettman MJ, Jonson JR, et al. Responses to cholecystoki nin octapeptide in papients with functional abdominal 1 pain syndromes[J]. J Gastroenteral Hepato,1992, 7(3):293-297.
[67]Chey W Y, Jin H O, Lee M H, et al. Colonic motility abnormality in patients with irritable bowe] syndrome exhibiting abdominal pain and diarrhea[J]. Am J Gastroenterology, 2001,96(5):1499.
[68]梁荣新,郑琴芳,梁列新,等.肠易激综合征与胃肠激素的关系[J].中国综合临床,2004,20(8)：702-703.
[69]张志雄,粱荣新,郑琴芳,等.胃肠肽胆囊收缩素、胃动素的相关性[J].诊断学理论与实践,2006,5(1)：24-26.
[70]郑琴芳,梁荣新,蔡联英,等.肠易激综合征与乙状结肠胃肠激素的关系[J].广西医学,2007,29(3)：333-334.
[71]Sugimachi M, Kiyohara T, Murayama Y, et al. Endogenous endothelin in a rat model of acute colonic mucosal injury[J]. J Gastroenterol Hepatol,2000,15:1125-1131.
[72]韩炜,郭成浩,李延青,等.肠易激综合征患者内皮素和一氧化氮含量变化的意义[J].胃肠病学,2002,7(6)：342-344.
[73]王巍峰,杨云生,孙刚,等.肠易激综合征大鼠模型脊髓后角神经递质表达的改变[J].胃肠病学和肝病学杂志,2006,15(4)：405.
[74]Schuurkes JA, Van Neuten JM. Colonic mot i l ity abnormal i t,y in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea[J]. Scand J Gastroenterol Suppl, 1981,16:33-36.
[75]Dive A, Forot F, Jamart J, et al. Dysmotility of the small intes-tine in irritable bowel syndrome[J]. Intensive Care Mod,2000,26:901-907.
[76]Miyazawa T, Matsumoto M, Kato S, et al. Depression in patients of irritable bowel syndrome[J]. Med Sc i Monit,2003,9:71-77.
[77]Powell AK, Bywater RA. Endogenous nitric oxide release modulates the direction and frequency of colonic migrating motor complexes in theisolated mouse colon[J]. Neurogastroenterol M otil,2001,13:221-228.
[78]Hokari R, Kato S, Matsuzaki K, et al. Reduced sensitivity of inducible nitric oxide synthase deficient mice to chronic colitis[J]. Free Radic Biol Med,2001,31:153-163.
[79]Konturek SK, Konturek PC. Role of nitricoxide in the digestive system [J]. Digestion, 1995,56(1):1-13.
[80]韩炜,郭成浩,李延青,等.肠易激综合征患者内皮素和—氧化氮含量变化的意义[J].胃肠病学,2002,7(6)：342-344.
[81]Wu HG, Jiang B, Zhou EH, et al. Regula-tory mechanism of electroa cupuncture in irritable bowel syndrome:preventing MC activation and decreasing SP> VIP Secretion[J]. Dig Dis Sci,2008,53(6):1644-1651.
[82]梁杰贤,洪迅,季文进,等.辣椒素受体在腹腔注射内皮素引起内脏痛中的作用[J].中国疼痛医学杂志,2006,12(3)：167-169.
[83]Akbar A, Yiangou Y, Facer P, et al. Increased capsaicin receptor TRPV1 expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain[J]. Gut,2008,57(7):923-929.
[84]Lu CL, Chen C Y, Chang FY. et al. Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome[J]. J Gastroenterol Hepetol,2001, 15(8):925.
[85]Spence MJ, Moss-Morris R. The cognitive behaviour al model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis[J]. Gut,2007,56(8): 1066-1071.
[86]Asahina S, Hasegawa K, Tsuboi K. Depression in patients of irritable bowel syndrome[J]. Nippon Rinsho,2006,64(8):1527-1531.
[87]Ladep NG, Obindo T J, Audu MD, et al. Depression in patients with irritable bowel syndrome in Jos, Nigeria[J]. World J Gastroenterol,2006,12(48):7844-7847.
[88]Choung RS, Locke GR 3rd, Zinsmeister AR, et al. Psychosocial distress and somatic symptoms in community subjecs with irritable bowel syndrome:a psychological component is the rule[J]. Am J Gastroenterol,2009,104(7):1772-1779.
[89]干建华.流行病学[M],第五版,北京：人民卫生出版社,2007：31-35.
[90]蒋峰.中国贫困地区女性健康状况分析[J].生殖健康社会科学研究进展,1996,417-421.
[91]A kim. The determination of infant and child mortality in Tanzania. Health policy and plainly[J],1995,4:384-394.
[92]David AS, Elizabeth AW, Andrew SK. Material employment and reproductive riskfators. AM J epidemioK[J],1990,132:933-945.
[93]刘民,李竹.流行病学研究方法在生殖健康研究的应用.中华流行病学杂志[J],2003,24(8)： 11-13.
[94]赵仲堂.流行病学研究方法与应用[M],第二版,北京：科学出版社,2003：69-97.
[95]胡浩,姜宝.高琦等流行病学研究进展[J].中国公共卫生,2008,7,24(7)：19-20.
[96]夏愔愔,詹思延.队列研究.中国循证儿科杂志[J],2009,7(4)：2.1
[97]梁戈玉,浦跃朴,尹立红.5种基因与某些环境因素在肺癌发生中交互作用的单纯病例.环境与职业医学[J],2006,23(6)：449-453.
[98]易洪刚,陈峰.单纯病例研究.国外医学.流行病学传染病学分册[M],2004,31(1)：60-62
[99]梁万年,主编,医学科研方法学[M],第一版,北京：人民卫生出版社,2002：83-85.
[100]李素梅,陈海婴,袁昆华等.不同浓度碘盐对人群碘营养状况的现场试验研究.中华流行病学杂志[J],2005,26(10)：25-27.
[101]王滨有.社区干预试验及应用.中国地方病学杂志[J],2004,7,23(4)：52-54.
[102]邱泓,张茂鎔,沈岚等.昆明是社区居民糖尿病防治健康教育干预效果评估,中国初级卫生保健[J],2010,9,24(9)：41-43.
[103]邱冰峰,肠易激综合征的几点中医学认识[J].现代中西医结合杂志.2007,16(19)2661-2662.
[104]张涛.从肝脾论治肠易激综合征考辨[J].实用中医内科杂志,2008,22(7)：11-12.
[105]朱耀群,陈军贤,李军.补中益气汤加减治疗肠易激综合征89例疗效观察[J].实用医学杂志,1996,12(6)：399.
[106]彭志允,陈利国.从肝脾论治便秘型肠易激综合征[J].四川中医,2007,25(5)：23-24.
[107]王恩元,李柏群,魏大荣.调中固肠汤治疗腹泻型肠易激综合征54例[J].中国中西医结合消化杂志,2010,18(2)：122-123
[108]张声生,许文君,陈贞,等.疏肝健脾法与健脾化湿法治疗腹泻型肠易激综合征对比治疗观察[J].中华中医药杂志,2010,25(1)：127-130.
[109]周晓波.疏肝养阴法治疗肠易激综合征35例临床观察[J].上海中医药杂志,2007,41(10)：40-41.
[110]黄翌,赵长鹰.肠易激综合征从情致论治探讨[J].山东中医杂志,2004,23(10)：379.
[111]许筱颖,李德魁.崔应珉教授治疗肠易激综合征经验[J].河南中医,2004,24(3)：24-25.
[112]陈必勤,淦家荣.辨证治疗肠易激综合征94例[J].新中医,2003,35(1)：55-56.
[113]张书生.肠易激综合征从肺论治[J].四川中医,2005,23(3)：17-18.
[114]周福生,程宏辉,祝淑贞.心胃相关理论及临床应用[J].浙江中医学院学报,2004,28(2)：7.
[115]刘保成.从肝气阳虚论治肠易激综合征临床研究[J].中国中西医结合消化杂志,2001,9(3)：170-171.
[116]刘汉昌.中药治疗肠易激综合征34例疗效观察[J].中医杂志,1986,27(2)：6
[117]葛恒¨松.辨证分型治疗肠易激综合征62例[J].陕西中医,1998.19(7)：311.
[118]梁启明,王惠政.辨证分型治疗肠易激综合征68例[J].中国民间疗法,2000,8(12)：38-39.
[119]李乾构,周学文,单兆伟.实用中医消化病学[M].北京：人民卫生出版社,2001.527-547.
[120]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社,2002.139-143.
[121]高洪栓.辨证分型治疗肠道易激综合征55例[J].江苏中医药,2002,23(12)：24.
[122]陈必勤,淦家荣.辨证治疗肠易激综合征94例[J].新中医,2003,35(1)：55-56.
[123]李炜.辨证治疗肠易激综合征39例[J].山西中医,2004,20(5)：17-18.
[124]王庆成.辨证治疗肠易激综合征56例[J].河南中医,2004,24(4)：32-33.
[125]陈治水,张万岱,危北海,等.肠易激综合征中西医结合诊治方案(草案)[S].中国中西医结合消化杂志,2005,13(1)：65.
[126]邓照华.辨证治疗肠易激综合征40例[J].辽宁中医杂志,2006,33(1)：62.
[127]原培谦.辨证治疗肠易澈综合征76例[J].北京中医药大学学报,2007,14(2)：14-15.
[128]翟敏,金炜,吴炯.孙建华辨治肠易激综合征经验[J].上海中医药杂志,2008,42(2)：44-45
[129]刘敏.中医药辨证治疗肠易激综合征[J].中医中药,2008,5(22)：84.
[130]包艳莉,王垂杰.王垂杰教授治疗肠易激综合征经验[J].长春中医药大学学报,2008,24(1)：13.
[131]周军丽,张颖.中医辨证治疗腹泻型肠易激综合征[J].中国中医药信息杂志,2005,12(5)：57.
[132]余大强,乐伟芬,周签,等.中医辨证治疗肠易激综合征(腹泻型)疗效观察[J].中国中医药信息杂志,2005,12(6)：78-79.
[133]彭林.辨证分型治疗泄泻型肠易激综合征58例[J].江西中医药,2005,36(6)：27-28.
[134]范汉淮.辨证分型治疗腹泻型肠易激综合征4例[J].辽宁中医学院学报,2006,8(1)：47.
[135]刘水章.辨证治疗便秘型肠易激综合征45例临床观察[J].山西中医,2006,22(6)：12-13.
[136]李乾构,周学文,单兆伟.中医消化病诊疗指南[M].北京：中国中医药出版社,2006,90-94.
[137]海霞.朱文峰教授浅谈整肃辨证新体系[J].中国中医药报,2004,4(5)：5.
[138]柯雪帆.中医辨证学[M].上海：上海中医学院,1987.
[139]朱文峰.证素辨证新体系的内容及科学意义[J].湖南中医学院学报,2004,24(6)：38-39.
[140]严石林,雍小嘉,陶怡等.新的辨证“证素”症状判断指标研究[J].成都中医药大学学报,2011,34(1)：1-4.
[141]李亚,李素云,李建生等.流行性感冒中医证素分布规律的文献分析[J].辽宁中医杂志,2010,37(2)：238-240.
[142]李素云,李亚,邓丽等.弥漫性肺间质疾病中医证素分布与组合规律研究[J].中华中医药杂志,2011,26(6)：1289-1292.
[143]王至婉,李建生,余学庆等.社区获得性肺炎证素及其老年患者特征分析[J].辽宁中医杂志,2009,36(9)：1450-14151.
[144]王海峰,李建生,余学庆等.基于文献的重症肺炎中医证素组合规律研究[J].辽宁中医杂志, 2009,36(12)：2059-2060.
[145]王至婉,李建生,李素云等.慢性阻塞性肺疾病稳定期证素分布及组合规律[J].南京中医药大学学报,2010,26(4)：252-254.
[146]田德禄.中医内科学[M].北京：人民卫生出版社,2002.
[147]赵金铎.中医证候鉴别诊断学[M].人们卫生出版社,2004.
[148]何清波,苏炳华,钱元.医学统计学及其软件包[M].上海：上海科学技术文献出版社,2003,285.
[149]李永健,方肇勤,邸若虹.聚类分析在中医药研究中的应用与思考[J].中国中医药信息杂志,2001,8(6)：8.
[150]孟庆刚,郭书文.如何将数学方法应用于现代中医药研究[J].中国中医药信息杂志,2000,7(8)：21.
[151]何裕民.体质聚类研究与辨证体系重建[J].中医研究,1996,9(5)：1.
[152]汪红兵,张声生.肠易激综合征中医证候学特点的认知和探索[J].世界华人消化杂志,2010,18(21)：2210-2215.
[153]黄虹,刘劲松.罗马III标准诊断肠易激综合征各亚型临床症状特点分析[J].临床内科杂志,2008,25(12)：833-835.
[154]Reshetnikov OV, Kurilovich SA, Denisova DV, et al. Prevalence of dyspepsia and irritable bowel syndrome a-mong adolescent of Novosibirsk, western Siberia[J]. Int J Circumpolar Health,2001,60(2):253-257.
[155]Bennett G, Talley NJ. Irritable bowel syndrome in the el-derly[J]. Best Pract Res Clin Gastroenterol,2002,16(1):63-76.
[156]Masud MA, Hasan M, Khan AK. Irritable bowel syn-drome in a rural community in Bangladesh:prevelance, symptoms pattern, and health care seeking behavior[J]. Am J Gastroenterol,2001,96(5):1547-1552.
[157]姚欣,杨云生,赵卡冰等.罗马III标准研究肠易激综合征临床特点及亚型[J].世界华人消化杂志,2008,16(5)：563-566.
[158]李定国,刘栋,许小幸,等.青少年儿童肠易激综合征的流行病学调查[J].中华消化杂志,2005,25(5)：266-269.
[159]Clive H Wilder-Smith, Joan Robert-Yap. Abnormal endogenous pain modulation and somatic and visceral hypersensi tivi ty in female patients wi th i rritable bowel syndrome[J]. ISSN 1007-9327 CN 14-1219/R World J Gastroenterol,2007,13(27):3669-3704.
[160]Ho YL, Emeran AM, Max S, et al. Gender-related differences in IBS symptoms[J]. Am J Gastroenterol,2001,96:2184-2193.
[161]姚健敏,陈淑洁，孙蕾民.浙江省肠易激综合征的流行病学和患者生活质量研究[J].中华内科杂志,2003,42：34-37.
[162]Jones R, Lydeard S. Irritable bowel syndrome population[J]. B M J,1992,304(6819): 87-90.
[163]Talley NJ, Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly.-a population-based study[J]. Gastroenterol,1992,102(3):895-901.
[164]Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices[J]. Obstet Gynecol,1996,87(1): 55-58.
[165]Bommelaer G, Rouch M, Dapoigny M, et al. Epidemiology of intestinal functional disorders in an apparently healthy population [J]. Gastroenterol Clin Biol,1986,10 (1): 7-12.
[166]Ruigomez A, Wallander MA, Johansson S, et al. One-year follow-up of newly diagnosed irritable bowel syndrome patients[J]. Aliment Pharmacol Ther,1999,13(8):1097-1102.
[167]Malak A. Bonaz B. Irritable bowel syndrome:a model of the brain-gut interaetions[J]. Med Sci Monit,2004,10(4):55-62.
[168]Vinton S. Chadwick.粘膜免疫系统在肠易激综合征中的作用.Gastroenterology[J], June 2002,122(7):78-81.
[169]李定国,周惠清,宋艳艳等.全国城市中小学生肠易激综合征现况调查[J].中华内科杂志[J],2007,46(2)：107-112.
[170]中华医学会消化病学分会胃肠动力学组.肠易激综合征的诊断和治疗的共识意见[J].中华消化杂志,2008,28(1)：38-40.
[171]赵菊辉,董蕾,郝筱倩.肠易激综合征患者小肠运动功能的研究[J].中华消化杂志,2007,27(1)：51-52.
[172]张英剑,王萍,金建军等.肠易激综合征患者胃运动功能与胃肠激素和心理因素的关系[J].临床内科杂志,2007,24(1)：54-56.
[173]张侃,谢小平,孙圣斌等.肠易激综合征患者近端胃舒张和排空功能的研究[J].ChinJGastroenterol,2007,12(5)：298-300.
[174]Wholwell PJ, Lupton EW, Eduran D, et al. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome[J]. Gut,1998,42:235-242.
[175]Wholwell PJ, Mccallum M, Greed FH, et al. Non-colonic features of irritable bowel syndrome[J]. Gut,1986,27:37-40.
[176]Drossman DA, Mckee DC. Psychosocial factors in the irritable bowel syndrome:a multivariate staff patients and non patients with irritable bowel syndrome[J]. Gastroenterlolgy,1998,95:701-708.
[177]Fukudo S, Nomura T, Hongo M. Impact of corticotrophin releasing hormone on gastrointestinal motility and adrenocorticotrophic hormone in normal controls and patients with irritable bowel syndrome[J]. Gut,1998,42:845-849.
[178]游元明,刘劲松.肠易激综合征感觉异常研究进展.国际消化病杂志[J],2007,27(3)167-171.
[179]中亚东,张峰.加味逍遥散治疗腹泻型肠易激综合征85例[J].河南中医药学刊,2000,15： 37.
[180]刘保成.从肝气(阳)虚论治肠易激综合征临床研究[J].中国中西医结合消化杂志,2001,9：170-171.
[181]姜寅光.从肝辨治腹泻型肠易激综合征验案2则[J].新中医,2007,39：68-69.
[182]骆洁恒.自拟痛泻疏肝散合黛力新治疗肠易激综合征临床观察[J].辽宁中医药大学学报,2009,11：120.
[183]崔莉红.从脾论治腹泻型肠易激综合征[J].陕西中医,2008,29：46-47.
[184]刘同坤,闫书文.从临床特点探讨肠易激综合症的中医辨证思路[J].中国中医药现代远程教育,2008,6：547-548.
[185]沈芸.蔡淦教授从肝脾论治肠易激综合征临床经验拾零[J].新中医,2002,34：12-13.
[186]董爱峰.从肝脾论治肠易激综合征的体会[J].四川中医,2008,26：36-37.
[187]吴兵,张声生.肠易激综合征腹泻型的证候学研究进展[J].北京中医,2007,26：312-314.
[188]李乾构,周学文,单兆伟.实用中医消化病学[M].北京：人民卫生出版社,2001：527-547.
[189]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社,2002：139-143.
[190]陈治水,张万岱,危北海.肠易激综合征中西医结合诊治方案(草案)[J].中国中西医结合消化杂志,2005,13：65-67.
[191]陆木兴.江南与岭南地区湿邪的特性及证治差异[J].浙江中医杂志,2002,8：326-327.
[192]莫润田,曾勇,吴定苏,等.岭南地区居住人群中医体质调查[J].江西中医学院学报,2010,22(2)：18-19
[193]张志斌,王永炎,吕爱平,等.论证候要素与证候靶点应证组合辨证[J].中医杂志,2006,47(7)：483-485.
[2]Saito YA, Schoenfeld P, Locke GR 3rd. The epidemiology of irritable bowel syndrome in North America:a systematic review[J]. Am J Gastroenterol,2002,97(8):1910-1915.
[3]Ringel Y, Sperber AD, Dross man DA. Irritable bowel syndrome[J]. Annu Rev Med,2001, 52:319-338.
[4]Schmulson M, Ortiz O, Santiago-Lomeli M, et al. Frequency of functional bowel disorders among healthy volunteers in Mexico city[J]. Dig Dis,2006,24(3-4):342-347.
[5]Chang FY, Lu CL Irritable bowel syndrome in the 21st century:perspectives from Asia or South-east Asia[J]. Gastroenterol Hepatol,2007,22(1):4-12.
[6]Vandvik P0, Lydersen S, Farup PG. Prevalence co morbidi ty and impact of irritable bowel syndrome in Norway[J]. Scand J Gastroenterol,2006,41(6):650-656.
[7]Celebi S, Acik Y, Deveci SE, et al. Epidemiological features of irritable bowel syndrome in a Turkish urban society[J]. Gastroenterol Hepatol,2004,19:738-743.
[8]Kang JY. Systematic review:the influence of geography and ethnici ty in irri table bowel syndrome[J]. Aliment Pharmacol Ther,2005,21(3):663-676.
[9]Shinozaki M, Fukudo S, Hongo M, et al. High prevalence of irritable bowel syndrome in medical outpatients in Japan[J]. Gastroenterol,2008,42(9):1010-1016.
[10]Park KS, Ahn SH, Hwang JS, et al. A survey about irritable bowel syndrome in South Korea prevalence and observable organic abnormalities in IBS patients[J]. Dig Dis SCI, 2008,53(3):704-711.
[11]潘国宗,鲁素彩,柯美云,等.北京地区肠易激综合征的流行病学研究：一个整群、分层、随机的调查[J].中华流行病学杂志,2000,21(1)：26-28.
[12]熊理守,陈旻湖,陈惠新,等.广东省社区人群肠易激综合征的流行病学研究[J].中华医学杂志,2004,84：278-281.
[13]冯新伟,徐珊.香港特区老年人肠易激综合征流行病学调查分析[J].承德医学院学报,2009,11(1)：43-45.
[14]李定国,刘栋,许小幸,等.青少年儿童肠易激综介征的流行病学调查[J].中华消化杂志,2005,25(5)：266-269.
[15]周小玲,周立平，蔡文智.肠易激综合征的流行病学调查[J].中医药导报.2010,16(5)：98-100.
[16]罗莎,陈春华.南宁市肠易激综合征流行病学调查[J].中医误诊学杂志,2012,12(1)：130.
[17]Tamsel S, Demirpolat G, Killi R, et al. Primary hepatic actinormycosis a case of inflammatory pseudo tumor (case report)[J]. Tani Girisim Radyol,2004,10(2):154-157.
[18]Corapcioqlu F, Kargi A, Olgun N, et al. Inflammatory my of ibroblastic turn or of the ileocecal mesentery mimicking abdominal lymphoma in childhood report of two cases[J]. Surg Today,2005,35(8):687-691.
[19]陈毅斌,张宝庭,张锡迎,等.肠道感染后IBS与SERT基因多态性关系[J].现代医院,2010,10(3)：11-13.
[20]Whorwell PJ, McCalum M, Creed FH, et al. Non-colonic features of irritable bowel syndrome[J], Gut,1986,27:37-40.
[21]Yuri A, Gloria M, Joseph J, et al. Familial aggregation of irritable bowel syndrome: A family case control study[J]. Am J Gastroenterol,2010,105:838-841.
[22]Kanazawa M, Endo Y, Whitehead WE, et al. Patients and nonconsulters with irritable bowel problems have more impaired psychological distress[J]. Dig Dis Sci,1994,49: 1046-1953.
[23]高峰,王景杰,黄裕新,等.肠易激综合症16例胃肠运动功能临床探讨[J].陕西医学杂志,2007,8(8)：1903-1905.
[24]van der Voort IR, Osmanoglou E, SeyboldM, et al. Electrogastrography as a diagnostic tool fordelayed gastric emptying in functional and irritable bowel syndrome[J]. Neurogastroenterol Moti,2003,15(5):467-473.
[25]Portincasa P, Moschetta A, Baldassarre G, et al. Pan-enteric dysmo tility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome[J]. World J Gastroenterol,2003,9(10):2293-2299.
[26]陶琳,柯美云,王智凤.小肠细菌过度生长与功能性胃肠疾病的关系[J].中国中西医结合消化杂志,2005,13(2)：122-123.
[27]王景杰,高峰,黄欲新,等.IBS患者胃肠运动功能的临床研究[J].西安交通大学学报,23(4)：423-424.
[28]段建华,赵洪川.便秘型肠易激综合征患者结、直肠肛门动力学的临床研究[J].胃肠病学和肝病学杂志,2006,15(2)：191-193.
[29]Manabe N, Wong BS, Camilleri M, et al. Lower functional gastrointrstinal disorders: evidence of abnormal colonic transit in a 287 patient cohort [J]. Neurogastroenterol Motil, 2010,22(3):293-296.
[30]Staud R, Spaeth M. Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia[J]. CNS Spectr,2008,13(3):12217.
[31]Wilder-Smith CH, Robert-Yap J. Abnormal endogenous pain modulation and somatic and visceral hypersensivity in female patients with irritable bowel syndrome[J]. World J Gastroenterol,2007,13(27):3699-3704.
[32]姜敏,汤浩,刘峥艳,等.肠易激综合征内脏感知异常与临床症状的相关性[J].世界华人消化杂志,2005,13(4)：561-564.
[33]Holtmann G, oebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? [J]. Am J Gastroenterol,1997,92(2):954-959.
[34]Defilippi GC, Quera PR, Madrid SAM, et al. Rectal barosstat in irritable bowel syndrome[J]. Rev Med Chill,2006,134(12):1524-1529.
[35]Spaziani R, Bayati A, Redmond K, et al. Vagal dysfunction in irritable bowel syndrome assessed by trctal distension and baroreceptor Sensitity[J]. Neurogastroenterol Motil, 2008,20(4):336-342.
[36]张鸣鸣,姜敏.肠易激综合征发病机制研究进展[J].世界华人消化杂志,2009,17：2484-2490.
[37]Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome:a double-blind, randomized, placebo-controlled study[J]. Am J Gastroenterol,2003,98(2):412-419.
[38]Tornblom ll, Lindberg G, Nvberq B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome[J]. Gastroenterology, 2002,123(6):1972-1979.
[39]Wang LH, Fang XC, Pan GZ. Bacil lary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis[J]. Gut 2004,53:1096-1101.
[40]Jung IS, Kim HS, Park H, Lee SI. The clinical course of post infectious irritable bowel syndrome:a five-year follow-up study[J]. Clin Gastroenterol,2009,43:534-540.
[41]Mearin F, Perez-Oliveras M, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak:one-year follow-up cohort study[J]. Gastroenterology,2005,129:98-104.
[42]Spiller RC. Role of infection in irritable bowel syndrome [J]. Gastroenterol,2007, 42(17):41-47.
[43]O'M ahony L, Me Carthy J, Kelly P, et al. Lactobacillus and bifidobac-terium in irritable bowel syndrome:symptom responses and relation-ship to cytokine profiles[J]. Gastroenterology,2005,128(3):541-551.
[44]Wu HG, Jiang B, Zhou EH, et al. Regulatory mechanism of electroacupuncture in irritable bowel syndrome:preventing MC activation and decreasing SP VIP secretion[J]. Dig Dis Sci,2008,53:1644-1651.
[45]Shi XZ, Sarna SK. Gene therapy of Ca(v) 1.2 channel with VIP and VIP receptor agonists and antagonists:a novel approach to designing promotility and antimoti1ity agents[J]. Am J Physiol Gastrointest Liver Physiol,2008,295:G187 G196.
[46]Bnnks MR, FrthingMJ, Robbcrecht P, etal. Ant isccretory act ions of a novel vasoactive intestinal polypeptide antagonist in human and rat small intestine[J]. Br P J Pharmacol, 2005,144(7):994-1001.
[47]Wu CT, Eiserich JP, Gershwin ME, et al. M yeloperoxidase positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions[J]. Hepatology,2003,38(4):1018-1025.
[48]王晓,尹朝礼,胡道松,等.肠动力疾病结肠壁内NOS, AchE及SP阳性神经的分布[J].中华消化杂志,1997,17(4)：195.
[49]张忠兵,张学庸,邓敬兰,等.溃疡性结肠炎、肠易激综合征和慢性结肠炎病人黏膜中SP和V1P含量的初步探讨[J].中华消化杂志,1993,13(2)：93.
[50]林琳,赵志泉,殷咏梅,等.胃肠激素与肠易激综合征的相关性[J].江苏医药杂志,2001,27(3)：166.
[51]杨云生,张万岱,潘德寿,等.肠易激综合征血浆及乙状结肠黏膜中CCK及SP的含量[J].消化病学杂志,1997,5(7)：437.
[52]Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydrox-ytryptamine in diarrhoea predominant irritable bowel syndrome:a pilot study [J]. Gut,1998,42(1):42.
[53]Grider JR, Piland BE. The peristaltic reflex induced by short-chain Fatty acids is mediated by sequential release of 5-HT and neuronal CGRP but not BDNF[J]. Am J Physiol Gastrointest Liver Physiol,2007,292(1):G429-G437.
[54]Miwa J, Echizen H, Matsueda K, etal. Patients with constipation prediminant irritable bowel syndrome may have elevated sero-tonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits[J]. Diges-tion, 2001,63(3):188.
[55]Gorard DA, Dewsnap PA, Medbak SH, et al. Central 5-hydroxytryp-taminergic function in irritable bowel syndrome[J]. Scared J Gastroen-terol,1995,30(10):994.
[56]Spiller RC, Jenkins D, Thornley JP, et al. Increased rental mucosal enteroendocrine cells T lymphocytes end increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome[J]. Gut,2000,47(6):804.
[57]Bose M, Nickols C, Feakins R, etal.5-hydroxytrypatamine and enterochapmaffin cells in the irritable bowel syndrome[J]. Gastroenterology,2000,118:A563.
[58]Sjolund K, Ekman R, Lindgren S, etal. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome[J]. Scand-J-Gas-troenterol,1996,31(11):1110.
[59]谢勇,黄缘.王崇文,等.肠易激综合征乙状结肠粘膜内胃肠激素及一氧化氮的变化[J].中国内镜杂志,1997,3(6)：17.
[60]Gui X-Y. Mast sells:A possiblc link between psychological stress enteric infection food allergy and gut hypersensitivity in the irritable bowel syndrome[J]. J Gastroenterology and Hepatology,1998,13(10):980.
[6l]Talley NJ. Serotoninegic neuroenteric modulators[J]. Lancet,2001,358(9298):2061.
[62]杨云生,张振书,宋于刚,等.肠易激综合征发病机制的初步研究[J].中国病理生理志,1998,14(4)：395.
[63]王彝康,龙汉宁,孙依萍,等.肠易激综合征患者胃肠激素变化[J].胃肠病学,2001,6(2)1]6.
[64]Harvey RF, Read AE. Effects of cholecystokinin on colonic motility and symptoms in patients with the irritable bowel syndrome[J]. Lan-cet,1973,1(7793):1-3.
[65]Kellow JE, Phillips SF, Mller LJ, et al. Dysmotility of the small intes-tine in irritable bowel syndrome[J]. Gut,1988,29(9):1236-1243.
[66]Thomson IR, Fettman MJ, Jonson JR, et al. Responses to cholecystoki nin octapeptide in papients with functional abdominal 1 pain syndromes[J]. J Gastroenteral Hepato,1992, 7(3):293-297.
[67]Chey W Y, Jin H O, Lee M H, et al. Colonic motility abnormality in patients with irritable bowe] syndrome exhibiting abdominal pain and diarrhea[J]. Am J Gastroenterology, 2001,96(5):1499.
[68]梁荣新,郑琴芳,梁列新,等.肠易激综合征与胃肠激素的关系[J].中国综合临床,2004,20(8)：702-703.
[69]张志雄,粱荣新,郑琴芳,等.胃肠肽胆囊收缩素、胃动素的相关性[J].诊断学理论与实践,2006,5(1)：24-26.
[70]郑琴芳,梁荣新,蔡联英,等.肠易激综合征与乙状结肠胃肠激素的关系[J].广西医学,2007,29(3)：333-334.
[71]Sugimachi M, Kiyohara T, Murayama Y, et al. Endogenous endothelin in a rat model of acute colonic mucosal injury[J]. J Gastroenterol Hepatol,2000,15:1125-1131.
[72]韩炜,郭成浩,李延青,等.肠易激综合征患者内皮素和一氧化氮含量变化的意义[J].胃肠病学,2002,7(6)：342-344.
[73]王巍峰,杨云生,孙刚,等.肠易激综合征大鼠模型脊髓后角神经递质表达的改变[J].胃肠病学和肝病学杂志,2006,15(4)：405.
[74]Schuurkes JA, Van Neuten JM. Colonic mot i l ity abnormal i t,y in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea[J]. Scand J Gastroenterol Suppl, 1981,16:33-36.
[75]Dive A, Forot F, Jamart J, et al. Dysmotility of the small intes-tine in irritable bowel syndrome[J]. Intensive Care Mod,2000,26:901-907.
[76]Miyazawa T, Matsumoto M, Kato S, et al. Depression in patients of irritable bowel syndrome[J]. Med Sc i Monit,2003,9:71-77.
[77]Powell AK, Bywater RA. Endogenous nitric oxide release modulates the direction and frequency of colonic migrating motor complexes in theisolated mouse colon[J]. Neurogastroenterol M otil,2001,13:221-228.
[78]Hokari R, Kato S, Matsuzaki K, et al. Reduced sensitivity of inducible nitric oxide synthase deficient mice to chronic colitis[J]. Free Radic Biol Med,2001,31:153-163.
[79]Konturek SK, Konturek PC. Role of nitricoxide in the digestive system [J]. Digestion, 1995,56(1):1-13.
[80]韩炜,郭成浩,李延青,等.肠易激综合征患者内皮素和—氧化氮含量变化的意义[J].胃肠病学,2002,7(6)：342-344.
[81]Wu HG, Jiang B, Zhou EH, et al. Regula-tory mechanism of electroa cupuncture in irritable bowel syndrome:preventing MC activation and decreasing SP> VIP Secretion[J]. Dig Dis Sci,2008,53(6):1644-1651.
[82]梁杰贤,洪迅,季文进,等.辣椒素受体在腹腔注射内皮素引起内脏痛中的作用[J].中国疼痛医学杂志,2006,12(3)：167-169.
[83]Akbar A, Yiangou Y, Facer P, et al. Increased capsaicin receptor TRPV1 expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain[J]. Gut,2008,57(7):923-929.
[84]Lu CL, Chen C Y, Chang FY. et al. Effect of a calcium channel blocker and antispasmodic in diarrhoea-predominant irritable bowel syndrome[J]. J Gastroenterol Hepetol,2001, 15(8):925.
[85]Spence MJ, Moss-Morris R. The cognitive behaviour al model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis[J]. Gut,2007,56(8): 1066-1071.
[86]Asahina S, Hasegawa K, Tsuboi K. Depression in patients of irritable bowel syndrome[J]. Nippon Rinsho,2006,64(8):1527-1531.
[87]Ladep NG, Obindo T J, Audu MD, et al. Depression in patients with irritable bowel syndrome in Jos, Nigeria[J]. World J Gastroenterol,2006,12(48):7844-7847.
[88]Choung RS, Locke GR 3rd, Zinsmeister AR, et al. Psychosocial distress and somatic symptoms in community subjecs with irritable bowel syndrome:a psychological component is the rule[J]. Am J Gastroenterol,2009,104(7):1772-1779.
[89]干建华.流行病学[M],第五版,北京：人民卫生出版社,2007：31-35.
[90]蒋峰.中国贫困地区女性健康状况分析[J].生殖健康社会科学研究进展,1996,417-421.
[91]A kim. The determination of infant and child mortality in Tanzania. Health policy and plainly[J],1995,4:384-394.
[92]David AS, Elizabeth AW, Andrew SK. Material employment and reproductive riskfators. AM J epidemioK[J],1990,132:933-945.
[93]刘民,李竹.流行病学研究方法在生殖健康研究的应用.中华流行病学杂志[J],2003,24(8)： 11-13.
[94]赵仲堂.流行病学研究方法与应用[M],第二版,北京：科学出版社,2003：69-97.
[95]胡浩,姜宝.高琦等流行病学研究进展[J].中国公共卫生,2008,7,24(7)：19-20.
[96]夏愔愔,詹思延.队列研究.中国循证儿科杂志[J],2009,7(4)：2.1
[97]梁戈玉,浦跃朴,尹立红.5种基因与某些环境因素在肺癌发生中交互作用的单纯病例.环境与职业医学[J],2006,23(6)：449-453.
[98]易洪刚,陈峰.单纯病例研究.国外医学.流行病学传染病学分册[M],2004,31(1)：60-62
[99]梁万年,主编,医学科研方法学[M],第一版,北京：人民卫生出版社,2002：83-85.
[100]李素梅,陈海婴,袁昆华等.不同浓度碘盐对人群碘营养状况的现场试验研究.中华流行病学杂志[J],2005,26(10)：25-27.
[101]王滨有.社区干预试验及应用.中国地方病学杂志[J],2004,7,23(4)：52-54.
[102]邱泓,张茂鎔,沈岚等.昆明是社区居民糖尿病防治健康教育干预效果评估,中国初级卫生保健[J],2010,9,24(9)：41-43.
[103]邱冰峰,肠易激综合征的几点中医学认识[J].现代中西医结合杂志.2007,16(19)2661-2662.
[104]张涛.从肝脾论治肠易激综合征考辨[J].实用中医内科杂志,2008,22(7)：11-12.
[105]朱耀群,陈军贤,李军.补中益气汤加减治疗肠易激综合征89例疗效观察[J].实用医学杂志,1996,12(6)：399.
[106]彭志允,陈利国.从肝脾论治便秘型肠易激综合征[J].四川中医,2007,25(5)：23-24.
[107]王恩元,李柏群,魏大荣.调中固肠汤治疗腹泻型肠易激综合征54例[J].中国中西医结合消化杂志,2010,18(2)：122-123
[108]张声生,许文君,陈贞,等.疏肝健脾法与健脾化湿法治疗腹泻型肠易激综合征对比治疗观察[J].中华中医药杂志,2010,25(1)：127-130.
[109]周晓波.疏肝养阴法治疗肠易激综合征35例临床观察[J].上海中医药杂志,2007,41(10)：40-41.
[110]黄翌,赵长鹰.肠易激综合征从情致论治探讨[J].山东中医杂志,2004,23(10)：379.
[111]许筱颖,李德魁.崔应珉教授治疗肠易激综合征经验[J].河南中医,2004,24(3)：24-25.
[112]陈必勤,淦家荣.辨证治疗肠易激综合征94例[J].新中医,2003,35(1)：55-56.
[113]张书生.肠易激综合征从肺论治[J].四川中医,2005,23(3)：17-18.
[114]周福生,程宏辉,祝淑贞.心胃相关理论及临床应用[J].浙江中医学院学报,2004,28(2)：7.
[115]刘保成.从肝气阳虚论治肠易激综合征临床研究[J].中国中西医结合消化杂志,2001,9(3)：170-171.
[116]刘汉昌.中药治疗肠易激综合征34例疗效观察[J].中医杂志,1986,27(2)：6
[117]葛恒¨松.辨证分型治疗肠易激综合征62例[J].陕西中医,1998.19(7)：311.
[118]梁启明,王惠政.辨证分型治疗肠易激综合征68例[J].中国民间疗法,2000,8(12)：38-39.
[119]李乾构,周学文,单兆伟.实用中医消化病学[M].北京：人民卫生出版社,2001.527-547.
[120]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社,2002.139-143.
[121]高洪栓.辨证分型治疗肠道易激综合征55例[J].江苏中医药,2002,23(12)：24.
[122]陈必勤,淦家荣.辨证治疗肠易激综合征94例[J].新中医,2003,35(1)：55-56.
[123]李炜.辨证治疗肠易激综合征39例[J].山西中医,2004,20(5)：17-18.
[124]王庆成.辨证治疗肠易激综合征56例[J].河南中医,2004,24(4)：32-33.
[125]陈治水,张万岱,危北海,等.肠易激综合征中西医结合诊治方案(草案)[S].中国中西医结合消化杂志,2005,13(1)：65.
[126]邓照华.辨证治疗肠易激综合征40例[J].辽宁中医杂志,2006,33(1)：62.
[127]原培谦.辨证治疗肠易澈综合征76例[J].北京中医药大学学报,2007,14(2)：14-15.
[128]翟敏,金炜,吴炯.孙建华辨治肠易激综合征经验[J].上海中医药杂志,2008,42(2)：44-45
[129]刘敏.中医药辨证治疗肠易激综合征[J].中医中药,2008,5(22)：84.
[130]包艳莉,王垂杰.王垂杰教授治疗肠易激综合征经验[J].长春中医药大学学报,2008,24(1)：13.
[131]周军丽,张颖.中医辨证治疗腹泻型肠易激综合征[J].中国中医药信息杂志,2005,12(5)：57.
[132]余大强,乐伟芬,周签,等.中医辨证治疗肠易激综合征(腹泻型)疗效观察[J].中国中医药信息杂志,2005,12(6)：78-79.
[133]彭林.辨证分型治疗泄泻型肠易激综合征58例[J].江西中医药,2005,36(6)：27-28.
[134]范汉淮.辨证分型治疗腹泻型肠易激综合征4例[J].辽宁中医学院学报,2006,8(1)：47.
[135]刘水章.辨证治疗便秘型肠易激综合征45例临床观察[J].山西中医,2006,22(6)：12-13.
[136]李乾构,周学文,单兆伟.中医消化病诊疗指南[M].北京：中国中医药出版社,2006,90-94.
[137]海霞.朱文峰教授浅谈整肃辨证新体系[J].中国中医药报,2004,4(5)：5.
[138]柯雪帆.中医辨证学[M].上海：上海中医学院,1987.
[139]朱文峰.证素辨证新体系的内容及科学意义[J].湖南中医学院学报,2004,24(6)：38-39.
[140]严石林,雍小嘉,陶怡等.新的辨证“证素”症状判断指标研究[J].成都中医药大学学报,2011,34(1)：1-4.
[141]李亚,李素云,李建生等.流行性感冒中医证素分布规律的文献分析[J].辽宁中医杂志,2010,37(2)：238-240.
[142]李素云,李亚,邓丽等.弥漫性肺间质疾病中医证素分布与组合规律研究[J].中华中医药杂志,2011,26(6)：1289-1292.
[143]王至婉,李建生,余学庆等.社区获得性肺炎证素及其老年患者特征分析[J].辽宁中医杂志,2009,36(9)：1450-14151.
[144]王海峰,李建生,余学庆等.基于文献的重症肺炎中医证素组合规律研究[J].辽宁中医杂志, 2009,36(12)：2059-2060.
[145]王至婉,李建生,李素云等.慢性阻塞性肺疾病稳定期证素分布及组合规律[J].南京中医药大学学报,2010,26(4)：252-254.
[146]田德禄.中医内科学[M].北京：人民卫生出版社,2002.
[147]赵金铎.中医证候鉴别诊断学[M].人们卫生出版社,2004.
[148]何清波,苏炳华,钱元.医学统计学及其软件包[M].上海：上海科学技术文献出版社,2003,285.
[149]李永健,方肇勤,邸若虹.聚类分析在中医药研究中的应用与思考[J].中国中医药信息杂志,2001,8(6)：8.
[150]孟庆刚,郭书文.如何将数学方法应用于现代中医药研究[J].中国中医药信息杂志,2000,7(8)：21.
[151]何裕民.体质聚类研究与辨证体系重建[J].中医研究,1996,9(5)：1.
[152]汪红兵,张声生.肠易激综合征中医证候学特点的认知和探索[J].世界华人消化杂志,2010,18(21)：2210-2215.
[153]黄虹,刘劲松.罗马III标准诊断肠易激综合征各亚型临床症状特点分析[J].临床内科杂志,2008,25(12)：833-835.
[154]Reshetnikov OV, Kurilovich SA, Denisova DV, et al. Prevalence of dyspepsia and irritable bowel syndrome a-mong adolescent of Novosibirsk, western Siberia[J]. Int J Circumpolar Health,2001,60(2):253-257.
[155]Bennett G, Talley NJ. Irritable bowel syndrome in the el-derly[J]. Best Pract Res Clin Gastroenterol,2002,16(1):63-76.
[156]Masud MA, Hasan M, Khan AK. Irritable bowel syn-drome in a rural community in Bangladesh:prevelance, symptoms pattern, and health care seeking behavior[J]. Am J Gastroenterol,2001,96(5):1547-1552.
[157]姚欣,杨云生,赵卡冰等.罗马III标准研究肠易激综合征临床特点及亚型[J].世界华人消化杂志,2008,16(5)：563-566.
[158]李定国,刘栋,许小幸,等.青少年儿童肠易激综合征的流行病学调查[J].中华消化杂志,2005,25(5)：266-269.
[159]Clive H Wilder-Smith, Joan Robert-Yap. Abnormal endogenous pain modulation and somatic and visceral hypersensi tivi ty in female patients wi th i rritable bowel syndrome[J]. ISSN 1007-9327 CN 14-1219/R World J Gastroenterol,2007,13(27):3669-3704.
[160]Ho YL, Emeran AM, Max S, et al. Gender-related differences in IBS symptoms[J]. Am J Gastroenterol,2001,96:2184-2193.
[161]姚健敏,陈淑洁，孙蕾民.浙江省肠易激综合征的流行病学和患者生活质量研究[J].中华内科杂志,2003,42：34-37.
[162]Jones R, Lydeard S. Irritable bowel syndrome population[J]. B M J,1992,304(6819): 87-90.
[163]Talley NJ, Keefe EA, Zinsmeister AR, et al. Prevalence of gastrointestinal symptoms in the elderly.-a population-based study[J]. Gastroenterol,1992,102(3):895-901.
[164]Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices[J]. Obstet Gynecol,1996,87(1): 55-58.
[165]Bommelaer G, Rouch M, Dapoigny M, et al. Epidemiology of intestinal functional disorders in an apparently healthy population [J]. Gastroenterol Clin Biol,1986,10 (1): 7-12.
[166]Ruigomez A, Wallander MA, Johansson S, et al. One-year follow-up of newly diagnosed irritable bowel syndrome patients[J]. Aliment Pharmacol Ther,1999,13(8):1097-1102.
[167]Malak A. Bonaz B. Irritable bowel syndrome:a model of the brain-gut interaetions[J]. Med Sci Monit,2004,10(4):55-62.
[168]Vinton S. Chadwick.粘膜免疫系统在肠易激综合征中的作用.Gastroenterology[J], June 2002,122(7):78-81.
[169]李定国,周惠清,宋艳艳等.全国城市中小学生肠易激综合征现况调查[J].中华内科杂志[J],2007,46(2)：107-112.
[170]中华医学会消化病学分会胃肠动力学组.肠易激综合征的诊断和治疗的共识意见[J].中华消化杂志,2008,28(1)：38-40.
[171]赵菊辉,董蕾,郝筱倩.肠易激综合征患者小肠运动功能的研究[J].中华消化杂志,2007,27(1)：51-52.
[172]张英剑,王萍,金建军等.肠易激综合征患者胃运动功能与胃肠激素和心理因素的关系[J].临床内科杂志,2007,24(1)：54-56.
[173]张侃,谢小平,孙圣斌等.肠易激综合征患者近端胃舒张和排空功能的研究[J].ChinJGastroenterol,2007,12(5)：298-300.
[174]Wholwell PJ, Lupton EW, Eduran D, et al. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome[J]. Gut,1998,42:235-242.
[175]Wholwell PJ, Mccallum M, Greed FH, et al. Non-colonic features of irritable bowel syndrome[J]. Gut,1986,27:37-40.
[176]Drossman DA, Mckee DC. Psychosocial factors in the irritable bowel syndrome:a multivariate staff patients and non patients with irritable bowel syndrome[J]. Gastroenterlolgy,1998,95:701-708.
[177]Fukudo S, Nomura T, Hongo M. Impact of corticotrophin releasing hormone on gastrointestinal motility and adrenocorticotrophic hormone in normal controls and patients with irritable bowel syndrome[J]. Gut,1998,42:845-849.
[178]游元明,刘劲松.肠易激综合征感觉异常研究进展.国际消化病杂志[J],2007,27(3)167-171.
[179]中亚东,张峰.加味逍遥散治疗腹泻型肠易激综合征85例[J].河南中医药学刊,2000,15： 37.
[180]刘保成.从肝气(阳)虚论治肠易激综合征临床研究[J].中国中西医结合消化杂志,2001,9：170-171.
[181]姜寅光.从肝辨治腹泻型肠易激综合征验案2则[J].新中医,2007,39：68-69.
[182]骆洁恒.自拟痛泻疏肝散合黛力新治疗肠易激综合征临床观察[J].辽宁中医药大学学报,2009,11：120.
[183]崔莉红.从脾论治腹泻型肠易激综合征[J].陕西中医,2008,29：46-47.
[184]刘同坤,闫书文.从临床特点探讨肠易激综合症的中医辨证思路[J].中国中医药现代远程教育,2008,6：547-548.
[185]沈芸.蔡淦教授从肝脾论治肠易激综合征临床经验拾零[J].新中医,2002,34：12-13.
[186]董爱峰.从肝脾论治肠易激综合征的体会[J].四川中医,2008,26：36-37.
[187]吴兵,张声生.肠易激综合征腹泻型的证候学研究进展[J].北京中医,2007,26：312-314.
[188]李乾构,周学文,单兆伟.实用中医消化病学[M].北京：人民卫生出版社,2001：527-547.
[189]郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社,2002：139-143.
[190]陈治水,张万岱,危北海.肠易激综合征中西医结合诊治方案(草案)[J].中国中西医结合消化杂志,2005,13：65-67.
[191]陆木兴.江南与岭南地区湿邪的特性及证治差异[J].浙江中医杂志,2002,8：326-327.
[192]莫润田,曾勇,吴定苏,等.岭南地区居住人群中医体质调查[J].江西中医学院学报,2010,22(2)：18-19
[193]张志斌,王永炎,吕爱平,等.论证候要素与证候靶点应证组合辨证[J].中医杂志,2006,47(7)：483-485.